Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine

• Asıl Yazarlar: Jun Nomura (Yazar), Masafumi Seki (Yazar), Syori Abe (Yazar), Tadahiro Kobayashi (Yazar), Yoko Okitsu (Yazar), Noriko Fukuhara (Yazar), Shinichiro Takahashi (Yazar), Hideo Harigae (Yazar), Junichi Kameoka (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Herein, we report the case of a 22-year-old woman with hereditary spherocytosis (HS) whose condition worsened after administration of the coronavirus disease 2019 (COVID-19), mRNA vaccine 'BNT162b2 Pfizer-BioNTech.' The woman had been diagnosed with HS in 2005, and her condition remained s...